nonprofit logo

Cancer Research Institute

Learn about this cause: Is it Legit? Do I like the mission? What is the CEO's salary?

EIN: 131837442 ✦ New york, NY ✦ Designated as a 501(c)(3)

Shop smarter and support your favorite cause at the same time! With the Give Freely browser extension, you'll automatically save money with coupons, and partner stores will donate to your chosen charity - at no extra cost to you. Start giving back with a single click. It's safe, free, and spam-free, guaranteed!

Overview

What is Cancer Research Institute?

The Cancer Research Institute (CRI) is a New York-based nonprofit organization dedicated to saving lives by fueling the discovery and development of effective immunotherapies for various types of cancer. They achieve this by funding laboratory, translational, and clinical research aimed at harnessing the power of the immune system for cancer diagnosis, treatment, and cure. The organization grants up to $200,000 over two years to qualified scientists investigating clinically relevant questions related to optimizing cancer immunotherapies. With a mission to advance immunology and immunotherapy, CRI also coordinates educational conferences and disseminates information on tumor immunology to the media, public, and scientific communities. The Cancer Research Institute employs a team of 36 individuals.


Official website here: www.cancerresearch.org

Is Cancer Research Institute legitimate?

Cancer Research Institute is a legitimate nonprofit organization registered as a 501(c)(3) entity. Cancer Research Institute submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.


Heare are some key statistics you may want to consider:

Executive Compensation: $2,513,200
Professional Fundraising Fees: $0
Other Salaries and Wages: $1,702,495

For more financial information, click here


Official website here: www.cancerresearch.org

What is the mission statement of Cancer Research Institute?

The Cancer Research Institute is dedicated to saving lives by driving the discovery and development of effective immunotherapies for various types of cancer. To accomplish this, the organization funds laboratory, translational, and clinical research aimed at utilizing the immune system to diagnose, treat, and cure cancer. The Cancer Research Institute also coordinates educational conferences on immunology and immunotherapy and disseminates information about advancements in tumor immunology to various communities. In summary, the Cancer Research Institute is a leading institute focused on fueling the advancement of immunotherapies to combat cancer and improve patient outcomes.


Official website here: www.cancerresearch.org

Who is the CEO of Cancer Research Institute?

Jill O'Donnell-Tormey is the Principal Officer of Cancer Research Institute. The CEO's salary of Cancer Research Institute is $500,953 and their total compensation is $564,003.


Official website here: www.cancerresearch.org

What is the revenue of Cancer Research Institute?

Cancer Research Institute's revenue in 2022 was $33,675,150.


Official website here: www.cancerresearch.org

Who are the executives of Cancer Research Institute and what are their salaries?

The average compensation at Cancer Research Institute during 2022 was $117,103. There are 36 employees and 340 volunteers at Cancer Research Institute.


Here are 48 key members and their salaries (Cancer Research Institute's CEO's salary is $500,953 and their total compensation is $564,003):


Alex Mishurov (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Alexander P Lynch (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Andrew K Tsai (Chairman)
  • Compensation: $0
  • Related: $0
  • Other: $0
Andrew M Paul (Vice Chairman)
  • Compensation: $0
  • Related: $0
  • Other: $0
Brian J Brille (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Diane Tuft (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Donald J Gogel (Vice Chairman)
  • Compensation: $0
  • Related: $0
  • Other: $0
Edgar R Berner (Vice Chairman)
  • Compensation: $0
  • Related: $0
  • Other: $0
Frank Vsica (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Geoffrey O Coley (Treasurer)
  • Compensation: $0
  • Related: $0
  • Other: $0
Glenn J Desimone (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Jacques C Nordeman (Vice Chairman (Thru 11/21))
  • Compensation: $0
  • Related: $0
  • Other: $0
James A Stern (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Jim Weiss (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Lauren Sveronis (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Lief D Rosenblatt (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Margot E Freedman (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Michael B Targoff (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Michael J Petrick (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Michael M Kellen (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Michael R Crawford (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Mitra Lohrasbpour (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Oliver R Grace Jr (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Paul C Shiverick (Chairman)
  • Compensation: $0
  • Related: $0
  • Other: $0
Peter L Bloom (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Peter Zhou (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Robert S Stolar (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Ronald G Weiner (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Sandra Coudert Graham (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Sarah Kim (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Sean P Fahey (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Thomas G Mendell (Secretary)
  • Compensation: $0
  • Related: $0
  • Other: $0
Tony Alvarez Ii (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
W Robert Dahl (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
William S Goldberg (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Yacov Arnopolin (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Jill O'Donnell-Tormey Phd (Ceo/Dir. Of Scientific Affairs)
  • Compensation: $500,953
  • Related: $0
  • Other: $63,050
Alfred R Massidas (Cfo/Dir. Of Human Resources)
  • Compensation: $324,388
  • Related: $0
  • Other: $77,455
Lynne A Rapino (Chief Program Officer)
  • Compensation: $268,914
  • Related: $0
  • Other: $75,404
Jay R Campbell (Managing Dir. Of Cri Clinical Accelerator And Vent)
  • Compensation: $249,581
  • Related: $0
  • Other: $53,388
Sharon S Slade (Chief Marketing Officer)
  • Compensation: $244,521
  • Related: $0
  • Other: $53,960
Brian M Brewer (Chief Communications Officer)
  • Compensation: $200,270
  • Related: $0
  • Other: $54,190
Rupinder Kaur (Chief Information Officer)
  • Compensation: $174,281
  • Related: $0
  • Other: $51,354
Deanne T Marbach (Director Of Major Gifts)
  • Compensation: $136,458
  • Related: $0
  • Other: $47,364
Qing Hua Zhang (Controller)
  • Compensation: $133,888
  • Related: $0
  • Other: $47,133
Marla S Lawson (Assoc. Dir. Of Corporate And Foundation Relations)
  • Compensation: $119,981
  • Related: $0
  • Other: $45,778
Shasell Negron (Assoc. Dir. Of Community Fundraising)
  • Compensation: $110,151
  • Related: $0
  • Other: $40,228
Samik K Upadhaya (Asst. Dir. Of Scientific Affairs)
  • Compensation: $110,144
  • Related: $0
  • Other: $34,277


Official website here: www.cancerresearch.org

Where can I find the form 990 for Cancer Research Institute?

Cancer Research Institute's most recent form 990 was submitted in 2022 and can be accessed here.


Official website here: www.cancerresearch.org

Learn more at the official website: www.cancerresearch.org

Mission Statement of Cancer Research Institute

Cancer Research Institute (CRI) is a mission-driven organization dedicated to saving lives by fueling the discovery and development of effective immunotherapies for all types of cancer. To accomplish this noble goal, CRI invests in laboratory, translational, and clinical research aimed at harnessing the power of the immune system to diagnose, treat, and ultimately cure cancer.

CRI's relentless pursuit of innovation extends beyond the walls of research facilities. The institute also coordinates scientific, medical, and patient education conferences on immunology and immunotherapy, and disseminates crucial information about advances in tumor immunology to various communities. This includes the media, the public, and the medical and scientific spheres, ensuring that knowledge about these groundbreaking developments is widely accessible.

In essence, Cancer Research Institute is a beacon of hope in the fight against cancer. By funding research and fostering collaboration, CRI is igniting the flame of innovation that drives the scientific community to unlock the keys to diagnosing, treating, and curing this complex disease. Through their unwavering commitment to excellence and their dedication to sharing knowledge, CRI is making a significant impact on the lives of cancer patients and their loved ones.

Shop smarter and support your favorite cause with the Give Freely browser extension. Save money with coupons and donate to charity with a single click. Download now!

Impact




October, 2024

Cancer Research Institute significantly impacts the field of oncology by advancing the discovery and development of immunotherapies, which harness the body’s immune system to combat cancer. Through its Clinic and Laboratory Integration Program (CLIP), the institute supports qualified scientists addressing clinically relevant questions that enhance the effectiveness of cancer treatments. By funding basic, preclinical, and translational research, CLIP grants—providing up to $200,000 over two years—directly translate innovative findings into potential therapies that can be implemented in clinical settings.

Additionally, the institute plays a vital role in education by coordinating scientific and medical conferences focused on immunology and immunotherapy. It disseminates information about tumor immunology advancements to the broader public, medical, and scientific communities, ensuring both professionals and patients stay informed about the latest developments in cancer treatment. Through these initiatives, the Cancer Research Institute is dedicated to saving more lives and empowering the ongoing fight against all types of cancer.




This information is meant to be a general summary of Cancer Research Institute. Please take the time to review official sources before making any decisions based upon the content provided here.


Financials

This financial information is from Propublica.

Revenue
$33,675,150 (2022)
Expenses
$31,314,716 (2022)
Efficiency

Other financial information:

This information is from the most recently submitted tax form from this organization, which was in 2022.

  • Investment Income: $4,910,453
  • Gross Receipts: $42,321,525

Assets and Liabilities:

  • Total Assets: $130,438,312
  • Total Liabilities: $63,733,550
  • Net Assets: $66,704,762

Want to help this charity, for free? You can click here to learn more about Give Freely

Organization Details

Founding Year

1953

Principal Officer

Jill O'Donnell-Tormey

Main Address

29 BROADWAY 4TH FLOOR, NEW YORK, NY, 10006

NTEE Category

Code: H300 - Medical research

If you are a representative of Cancer Research Institute and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.